We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 15.44%
2 Technology 14.68%
3 Financials 12.75%
4 Industrials 11.1%
5 Energy 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNBKA
1051
DELISTED
Century Bancorp Inc/Mass
CNBKA
$488K ﹤0.01%
13,800
– –
PULB
1052
DELISTED
PULASKI FINANCIAL CORP
PULB
$488K ﹤0.01%
42,800
– –
UVV icon
1053
Universal Corp
UVV
$1.1B
$487K ﹤0.01%
8,800
+7,000
+389% +$381K
ZEP
1054
DELISTED
ZEP INC COM STK (DE)
ZEP
$486K ﹤0.01%
27,500
– –
FRME icon
1055
First Merchants
FRME
$2.62B
$484K ﹤0.01%
22,900
– –
GPN icon
1056
Global Payments
GPN
$23.5B
$483K ﹤0.01%
13,272
– –
EVER
1057
DELISTED
Everbank Financial Corp
EVER
$483K ﹤0.01%
23,944
+3,114
+15% +$60K
XL
1058
DELISTED
XL Group Ltd.
XL
$483K ﹤0.01%
14,755
-129,645
-90% -$4.16M
REXI
1059
DELISTED
RESOURCE AMERICA INC CL-A
REXI
$478K ﹤0.01%
+51,100
New +$444K
ARE icon
1060
Alexandria Real Estate Equities
ARE
$9.11B
$477K ﹤0.01%
6,148
-4,300
-41% -$323K
COR
1061
DELISTED
Coresite Realty Corporation
COR
$476K ﹤0.01%
14,400
+6,400
+80% +$202K
KLIC icon
1062
Kulicke & Soffa
KLIC
$4.12B
$475K ﹤0.01%
33,300
– –
GUR
1063
DELISTED
SPDR S&P Emerging Europe ETF
GUR
$474K ﹤0.01%
11,967
– –
IWR icon
1064
iShares Russell Mid-Cap ETF
IWR
$55.4B
$472K ﹤0.01%
11,620
– –
SVU
1065
DELISTED
SUPERVALU Inc.
SVU
$470K ﹤0.01%
8,171
– –
HBIO icon
1066
Harvard Bioscience
HBIO
$36.4M
$469K ﹤0.01%
10,310
– –
REX icon
1067
REX American Resources
REX
$1.41B
$469K ﹤0.01%
+38,400
New +$422K
WELL icon
1068
Welltower
WELL
$168B
$458K ﹤0.01%
7,312
+3
+0% +$189
ALTO icon
1069
Alto Ingredients
ALTO
$317M
$457K ﹤0.01%
+29,900
New +$414K
SON icon
1070
Sonoco
SON
$4.77B
$457K ﹤0.01%
10,400
+7,300
+235% +$308K
TOWR
1071
DELISTED
Tower International, Inc.
TOWR
$457K ﹤0.01%
12,400
– –
AAV
1072
DELISTED
Advantage Oil & Gas Ltd
AAV
$456K ﹤0.01%
67,700
-16,500
-20% -$100K
MNRK
1073
DELISTED
MONARCH FINANCIAL HOLDINGS INC COM STK
MNRK
$453K ﹤0.01%
42,548
– –
SCHL icon
1074
Scholastic
SCHL
$661M
$452K ﹤0.01%
+13,270
New +$433K
HIFS icon
1075
Hingham Institution for Saving
HIFS
$673M
$449K ﹤0.01%
5,650
+100
+2% +$7.32K
41 42
43
44 45

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.